A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Spasticity Related to Any Cause Except Cerebral Palsy
Trial Locations (1)

ST6 7AG

North Staffordshire Rehabilitation Centre. Midlands Partnership NHS Foundation Trust., Stafford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT04396704 - A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity. | Biotech Hunter | Biotech Hunter